Category: Uncategorized
Category: Uncategorized
Apple, Google, Microsoft, and Mozilla ban Kazakhstan’s MitM HTTPS certificate
This marks the second time browsers makers had to intervene and block a certificate used by the Kazakhstan government to spy on its citizens.
Read MoreMicrosoft is designing its own Arm chips for datacenter servers: Report
We already knew Microsoft was working to bring Arm-powered servers for internal use to its cloud datacenters. But what and when will this mean anything to its customers?
Read MoreMicrosoft to enable certification renewals for free starting in February 2021
Microsoft is making the certification renewal processor easier, but it’s also going to require more frequent validation starting next year.
Read MoreWhere Fedora fits in the new Red Hat/CentOS Stream Linux world
With CentOS Stream now “tracking ahead” of Red Hat Enterprise Linux, where exactly does that leave Fedora, Red Hat’s community Linux distro, and long-time RHEL test release?
Read MoreCan Thierry Delaporte revive Wipro?
Delaporte’s decision to simplify the company’s organisational structure is a smart move, but ultimately what will matter is execution.
Read MoreASPI warns Canberra about security risk with current data centre procurement approach
According to a new ASPI paper, one provider holds 54% of current data centre facilities contracts with the Australian government.
Read MoreMicrosoft says it identified 40+ victims of the SolarWinds hack
Microsoft says 80% of the victims it identified were located in the United States.
Read MoreService NSW not effectively handling private information: NSW Auditor-General
Report arrives following breaches earlier this year from emails spoofing Office 365 warnings.
Read MoreSpotify to launch in South Korea in 2021
The music streaming service will launch in South Korea in the first half of 2021.
Read MorePhobos launches Orbital, a tool for finding attack pathways and entry points into your network
After months of work, teasing, and planning, Phobos Orbital is out of beta and available for trials.
Read More